Lotus Pharmaceutical Co., Ltd. (TPE:1795)

Taiwan · Delayed Price · Currency is TWD

216.00

+2.00 (0.93%)

Apr 2, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals Segment	20.35B	18.47B	16.86B	14.50B	12.53B
Pharmaceuticals Segment Growth	10.20%	9.52%	16.28%	15.78%	18.81%
Others	420.30M	333.96M	339.39M	301.39M	236.11M
Others Growth	25.85%	-1.60%	12.61%	27.65%	-8.74%
Elimination	-263.02M	-218.95M	-245.38M	-171.32M	-112.78M
Total	20.51B	18.58B	16.96B	14.63B	12.65B
Total Growth	10.36%	9.59%	15.89%	15.68%	17.90%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	8.73B	7.77B	6.81B	5.92B	4.45B
United States Growth	12.38%	13.98%	15.18%	32.95%	37.87%
South Korea	5.80B	5.71B	5.59B	5.28B	5.25B
South Korea Growth	1.59%	2.25%	5.86%	0.51%	2.83%
Taiwan	2.57B	2.52B	2.41B	1.44B	-
Taiwan Growth	2.18%	4.28%	67.67%	-	-
Others	3.41B	2.59B	2.14B	2.00B	2.95B
Others Growth	31.59%	20.74%	7.18%	-32.17%	23.12%
Total	20.51B	18.58B	16.96B	14.63B	12.65B
Total Growth	10.36%	9.59%	15.89%	15.68%	17.90%

Source: S&P Global Market Intelligence.